These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 28754129

  • 1. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
    Han F, Li Y, Lu Q, Ma L, Wang H, Jiang J, Li Z, Li Y.
    Virol J; 2017 Jul 28; 14(1):145. PubMed ID: 28754129
    [Abstract] [Full Text] [Related]

  • 2. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC.
    Mol Carcinog; 2011 Jan 28; 50(1):47-57. PubMed ID: 21061268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R, Kausar H, Munjal C, Gupta RC.
    Carcinogenesis; 2011 Nov 28; 32(11):1697-705. PubMed ID: 21859835
    [Abstract] [Full Text] [Related]

  • 5. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H, Liu X, Liu Y, Zhang M, Lai Y, Hao Y, Wang Q, Shi D, Wang N, Luo XG, Ma W, Zhang TC.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30728257
    [Abstract] [Full Text] [Related]

  • 6. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC, DiMaio D.
    Proc Natl Acad Sci U S A; 2000 Nov 07; 97(23):12513-8. PubMed ID: 11070078
    [Abstract] [Full Text] [Related]

  • 7. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 07; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 8. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R, Aqil F, Jeyabalan J, Gupta RC.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):536-46. PubMed ID: 25304375
    [Abstract] [Full Text] [Related]

  • 9. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
    Nor Rashid N, Yusof R, Watson RJ.
    J Gen Virol; 2011 Nov 28; 92(Pt 11):2620-2627. PubMed ID: 21813705
    [Abstract] [Full Text] [Related]

  • 10. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL, Shin YK.
    Int J Mol Sci; 2015 May 29; 16(6):12243-60. PubMed ID: 26035754
    [Abstract] [Full Text] [Related]

  • 11. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L, Zhang E, Shi J, Li X, Zhou K, Zhang Q, Le AD, Tang X.
    Cancer Chemother Pharmacol; 2013 Mar 29; 71(3):713-25. PubMed ID: 23292117
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM, Bharti AC.
    Tumour Biol; 2016 Oct 29; 37(10):13137-13154. PubMed ID: 27449048
    [Abstract] [Full Text] [Related]

  • 13. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L, Xu C, Long J, Shen D, Zhou W, Zhou Q, Yang J, Jiang M.
    Oncotarget; 2015 Sep 15; 6(27):23930-43. PubMed ID: 26329329
    [Abstract] [Full Text] [Related]

  • 14. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 15; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 15. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D, Zhou J, Wang F, Shi H, Li Y, Li B.
    Arch Gynecol Obstet; 2015 Dec 15; 292(6):1345-54. PubMed ID: 26093522
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.
    Niu XY, Peng ZL, Duan WQ, Wang H, Wang P.
    Int J Gynecol Cancer; 2006 Dec 15; 16(2):743-51. PubMed ID: 16681755
    [Abstract] [Full Text] [Related]

  • 17. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T, Sasaki C, Weinberger P, Psyrri A.
    J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448
    [Abstract] [Full Text] [Related]

  • 18. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF, Wang N, Bi XN, Yu X, Xu XH, Wang YL, Zhao CQ, Luo B, Wang YK.
    Virol J; 2016 Apr 05; 13():60. PubMed ID: 27044426
    [Abstract] [Full Text] [Related]

  • 19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar 05; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B, Zhao C, Wang Y.
    Oncol Rep; 2017 Apr 05; 37(4):2324-2334. PubMed ID: 28260046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.